Notch inhibition suppresses nasopharyngeal carcinoma by depleting cancer stem-like side population cells

Oncology Reports

Volumn 28, Issue 2, 2012, Pages 561-566

  Yu, Shudong ^a,b   Zhang, Ruxin ^a   Liu, Fenye ^c   Wang, Hong ^a   Wu, Jing ^a   Wang, Yanqing ^a  

^a FUDAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Nasopharyngeal carcinoma; Notch inhibitor; Side population cells

Indexed keywords

N [[(3,5 DIFLUOROPHENYL)ACETYL]ALANYL 2 PHENYL]GLYCINE 1,1 DIMETHYLETHYL ESTER; NOTCH RECEPTOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIDE POPULATION CELL;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DIPEPTIDES; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASTIC STEM CELLS; RECEPTORS, NOTCH; SIDE-POPULATION CELLS; SIGNAL TRANSDUCTION;

EID: 84863425141     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1830     Document Type: Article

References (37)

1. Tao Q and Chan AT: Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 9: 1-24, 2007. (Pubitemid 47398642)
2. Kawasaki BT, Hurt EM, Mistree T and Farrar WL: Targeting cancer stem cells with phytochemicals. Mol Interv 8: 174-184, 2008.
3. Keysar SB and Jimeno A: More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther 9: 2450-2457, 2010.
4. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 65: 6207-6219, 2005. (Pubitemid 40994406)
5. Ho MM, Ng AV, Lam S and Hung JY: Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827-4833, 2007. (Pubitemid 46910191)
6. Wang J, Wei X, Ling J, Huang Y, Huo Y and Zhou Y: The presence of a side population and its marker ABCG2 in human deciduous dental pulp cells. Biochem Biophys Res Commun 400: 334-339, 2010.
7. Alison MR, Lim SM and Nicholson LJ: Cancer stem cells: problems for therapy. J Pathol 223: 147-161, 2011.
8. Pannuti A, Foreman K, Rizzo P, et al: Targeting Notch to target cancer stem cells. Clin Cancer Res 16: 3141-3152, 2010.
9. Wang M, Li JT, Zeng YX, Hou JH and Lin QQ: Expression and significance of Notch1, p21WAF1 and involucrin in nasopharyngeal carcinoma. Ai Zheng 24: 1230-1234, 2005 (In Chinese).
10. Zhang Y, Peng J, Zhang H, et al: Notch1 signaling is activated in cells expressing embryonic stem cell proteins in human primary nasopharyngeal carcinoma. J Otolaryngol Head Neck Surg 39: 157-166, 2010.
11. Yu S, Zhang R, Liu F, Hu H, Yu S and Wang H: Down-regulation of Notch signaling by a ã-secretase inhibitor enhances the radiosensitivity of nasopharyngeal carcinoma cells. Oncol Rep 26: 1323-1328, 2011.
12. Bao S, Wu Q, McLendon RE, et al: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 756-760, 2006. (Pubitemid 44949604)
13. + breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785, 2006.
14. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA and Rosen JM: WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 104: 618-623, 2007. (Pubitemid 46123074)
15. Yu S, Zhang R, Liu F, Hu H, Yu S and Wang H: Down-regulation of Notch signaling by a ã-secretase inhibitor enhances the radiosensitivity of nasopharyngeal carcinoma cells. Oncol Rep 26: 1323-1328, 2011.
16. Wang J, Guo LP, Chen LZ, Zeng YX and Lu SH: Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 67: 3716-3724, 2007. (Pubitemid 46762157)
17. Shi GM, Xu Y, Fan J, et al: Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J Cancer Res Clin Oncol 134: 1155-1163, 2008.
18. Huang Q, Li Y and Lin X: A survival analysis of nasopharyngeal carcinoma from 1995 to 2004 in Sihui, Guangdong. Bull Chin Cancer 3: 150-151, 2007.
19. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 284: 770-776, 1999. (Pubitemid 29291335)
20. Lino MM, Merlo A and Boulay JL: Notch signaling in glioblastoma: a developmental drug target. BMC Med 8: 72, 2010.
21. Lai EC: Notch signaling: control of cell communication and cell fate. Development 131: 965-973, 2004.
22. Fukaya R, Ohta S, Yamaguchi M, et al: Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Lett 291: 150-157, 2010.
23. Guo S, Liu M and Gonzalez-Perez RR: Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta 1815: 197-213, 2011.
24. Zhang Y, Li B, Ji ZZ and Zheng PS: Notch1 regulates the growth of human colon cancers. Cancer 116: 5207-5218, 2010.
25. Harrison H, Farnie G, Howell SJ, et al: Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 70: 709-718, 2010.
26. Yung WK: Tumor stem cells, notch, and the news. Neuro Oncol 12: 115, 2010.
27. Hu YY, Zheng MH, Cheng G, et al: Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells. BMC Cancer 11: 82, 2011.
28. Zhang XP, Zheng G, Zou L, et al: Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol Cell Biochem 307: 101-108, 2008. (Pubitemid 350238652)
29. Fan X, Khaki L, Zhu TS, et al: NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28: 5-16, 2010.
30. Sikandar SS, Pate KT, Anderson S, et al: NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res 70: 1469-1478, 2010.
31. Zhen Y, Zhao S, Li Q, Li Y and Kawamoto K: Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas. Cancer Lett 292: 64-72, 2010.
32. Nam Y, Aster JC and Blacklow SC: Notch signaling as a therapeutic target. Curr Opin Chem Biol 6: 501-509, 2002. (Pubitemid 34804774)
33. Tien AC, Rajan A and Bellen HJ: A Notch updated. J Cell Biol 184: 621-629, 2009.
34. Kopan R and Ilagan MX: Gamma-secretase: proteasome of the membrane. Nat Rev Mol Cell Biol 5: 499-504, 2004.
35. Suwanjunee S, Wongchana W and Palaga T: Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling. Anticancer Drugs 19: 477-486, 2008. (Pubitemid 351556399)
36. Vermeulen L, Sprick MR, Kemper K, Stassi G and Medema JP: Cancer stem cells - old concepts, new insights. Cell Death Differ 947-958, 2008. (Pubitemid 351712600)
37. Chikazawa N, Tanaka H, Tasaka T, et al: Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells. Anticancer Res 30: 2041-2048, 2010.